Men diagnosed at this hospital trust can access the following services:

• Diagnostic Facilities:
• Multiparametric MRI
• Transperineal biopsy under local anaesthetic
• Transperineal biopsy under general anaesthetic
• Choline PET
• PSMA (prostate-specific membrane antigen) PET scan
• Whole body MRI
• Isotope bone scan

• Treatment Facilities:
• Radical prostatectomy
• Robot assisted laparoscopic prostatectomy
• External beam radiotherapy (EBRT)
• Chemotherapy
• Joint specialist MDT clinic

• Support Service Facilities:
• Clinical Nurse Specialist (CNS) in all clinics
• Prostate cancer-specific CNSs
• Advanced PCa CNS
• Urology CNS
• Sexual function services
• Specialist continence services
• Psychological counselling

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	312	1163
Performance Status recorded	93%	44%
PSA completed	97%	59%
Gleason Score completed	N/A	N/A
TNM completed	62%	35%
Stage variable assigned	64%	43%

	Specialist MDT	National
No. of men with disease status determined	506	23477
Percentage of men diagnosed with metastatic disease	17%	17%
No. of men diagnosed with M1 (metastases)	87	N/A

These indicators could not be reported this year for England as we were unable to assign a patient to a particular risk group due to the unavailability of information on Gleason score in the Rapid Cancer Registration Dataset

	Treatment Centre
No. of men who received radical prostatectomy (2020-2021)	38
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%)	16%
No. of men who received radical prostatectomy (2019)	42
Adjusted percentage of men experiencing at least one GU complication (%)	5%
No. of men who received radical radiotherapy (2019)	119
Adjusted percentage of men experiencing at least one GI complication (%)